Partnerships and funding highlight AI's growing impact in biotechnology. Ultima Genomics and Sapio Sciences have partnered to integrate Sapio's AI-driven lab informatics with Ultima's low-cost sequencing platform, facilitating multiomics analysis and streamlined workflows. Separately, Penguin AI raised nearly $30 million to automate administrative healthcare tasks such as prior authorization and coding. VedaBio expanded its CRISPR diagnostics capabilities by licensing Mammoth Biosciences IP, aiming to offer faster, cost-effective pathogen detection. These advances accelerate research and clinical decision-making in complex biological datasets.